Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
NEW YORK, NY--(Marketwired - July 28, 2015) - Abeona Therapeutics, Inc. (NASDAQ: ABEO), a biopharmaceutical company focused on developing and delivering gene therapy and plasma-based products for...
-
NEW YORK, NY--(Marketwired - July 07, 2015) - Abeona Therapeutics, Inc. (NASDAQ: ABEO)Confirms SDF™ technology platform fractions provide significantly enhanced yields of PTB-101 SDF Alpha™...
-
NEW YORK, NY--(Marketwired - July 01, 2015) - Abeona Therapeutics, Inc. (NASDAQ: ABEO)Financings of approximately $40 million completed to advance rare disease product developmentAbeona Therapeutics...
-
NEW YORK, NY--(Marketwired - June 22, 2015) - Abeona Therapeutics begins trading today under ticker symbol ABEOCompany to ring NASDAQ closing bell today at 4:00 pm ETAbeona Therapeutics, Inc. (NASDAQ:...
-
NEW YORK, NY--(Marketwired - June 19, 2015) - Abeona Therapeutics is focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare...
-
DALLAS, TX and NEW YORK, NY--(Marketwired - June 17, 2015) - PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI), a biopharmaceutical company focused on developing and delivering gene therapy and...
-
NEW YORK, NY and CLEVELAND, OH--(Marketwired - June 15, 2015) - PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI)CRISPR-Cas9 Gene-Editing System Demonstrated Promising Efficacy in Repairing the FANCC...
-
NEW YORK, NY--(Marketwired - June 08, 2015) - PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI)Company Adds Third AAV Gene Program to Expand Pipeline and Become a leader in Gene Therapies for Severe...
-
DALLAS, TX and NEW YORK, NY--(Marketwired - June 01, 2015) - PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI), a biopharmaceutical company focused on developing and delivering gene therapy and...
-
DALLAS, TX and NEW YORK, NY--(Marketwired - May 29, 2015) - PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI), a biopharmaceutical company focused on developing and delivering gene therapy and...